Home » Topics » Regulatory

Regulatory
RSS

FDA approves Bayer's Stivarga for treatment of metastatic colorectal cancer

Sep. 28, 2012

Regeneron's Eylea receives second U.S. approval

Sep. 27, 2012

FDA approves denosumab in new indication

Sep. 25, 2012

FDA approves production of [11C]-choline injection for PET imaging

Sep. 14, 2012

FDA approves Genzyme's MS therapeutic

Sep. 13, 2012

FDA approves Pfizer's bosutinib for CML

Sep. 5, 2012

Teduglutide receives European marketing authorization for short bowel syndrome

Sep. 5, 2012

FDA approves Xtandi for metastatic castration-resistant prostate cancer

Sep. 3, 2012

New drug approved for IBS-C and CIC

Aug. 31, 2012

Nucynta ER approved for new indication in U.S.

Aug. 30, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 18, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 18, 2025.
Maintenance, man: Lilly’s phase III weight trial hits goals
BioWorld
Eli Lilly and Co. took another step toward adding a way for patients to hang onto their weight loss when the firm disclosed positive top-line data from the phase...
AI drug developer Insilico to raise $292 million in Hong Kong IPO
BioWorld
Insilico Medicine Inc. plans to raise HK$2.27 billion (US$292 million) in its IPO on the Hong Kong Securities Exchange to advance its clinical pipeline and invest...